Tags

Type your tag names separated by a space and hit enter

Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study.
Climacteric. 2022 Apr; 25(2):208-211.C

Abstract

OBJECTIVE

This prospective pilot study aimed to evaluate the effects of associating a neodymium:yttrium-aluminum-garnet (Nd:YAG) laser with a vaginal erbium laser (VEL), as a non-ablative photothermal therapy for superficial dyspareunia in postmenopausal women (PMW) suffering from genitourinary syndrome of menopause (GSM).

METHODS

Two groups of sexually active PMW reporting superficial dyspareunia were selected: one (15 patients, VEL) was treated using an erbium:yttrium-aluminum-garnet laser crystal (XS Fotona SMOOTH; Fotona, Ljubljana, Slovenia) with a wavelength of 2940 nm; in the other group (15 patients, VEL + Nd:YAG) this treatment was followed by Nd:YAG laser (Fotona SP Dynamis, PIANO mode) treatment. Treatment consisted of three laser applications at 30-day intervals. Symptoms were assessed before, after each laser application and after 1 and 3 months from the end of the treatment, using the subjective visual analog scale (VAS) for superficial dyspareunia.

RESULTS

Both groups showed a rapid and significant improvement of superficial dyspareunia over time (p < 0.001) independently from age and years since menopause. The VEL + Nd:YAG group showed a greater improvement of superficial dyspareunia (p < 0.001); this difference was evident since the first treatment and remained stable over time.

CONCLUSIONS

The addition of Nd:YAG to VEL may induce greater improvement in superficial dyspareunia in PMW with GSM.

Authors+Show Affiliations

Menopause and Osteoporosis Unit, San Rossore Clinical Center, Pisa, Italy.Department of Obstetrics and Gynecology, Pisa University Hospital, Pisa, Italy.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

35006008

Citation

Gambacciani, M, and T Fidecicchi. "Short-term Effects of an Erbium/neodymium Laser Combination in Superficial Dyspareunia: a Pilot Study." Climacteric : the Journal of the International Menopause Society, vol. 25, no. 2, 2022, pp. 208-211.
Gambacciani M, Fidecicchi T. Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study. Climacteric. 2022;25(2):208-211.
Gambacciani, M., & Fidecicchi, T. (2022). Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study. Climacteric : the Journal of the International Menopause Society, 25(2), 208-211. https://doi.org/10.1080/13697137.2021.2014809
Gambacciani M, Fidecicchi T. Short-term Effects of an Erbium/neodymium Laser Combination in Superficial Dyspareunia: a Pilot Study. Climacteric. 2022;25(2):208-211. PubMed PMID: 35006008.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study. AU - Gambacciani,M, AU - Fidecicchi,T, Y1 - 2022/01/10/ PY - 2022/1/11/pubmed PY - 2022/4/22/medline PY - 2022/1/10/entrez KW - Superficial dyspareunia KW - erbium laser KW - genitourinary syndrome of menopause KW - menopause KW - neodymium laser KW - vaginal atrophy SP - 208 EP - 211 JF - Climacteric : the journal of the International Menopause Society JO - Climacteric VL - 25 IS - 2 N2 - OBJECTIVE: This prospective pilot study aimed to evaluate the effects of associating a neodymium:yttrium-aluminum-garnet (Nd:YAG) laser with a vaginal erbium laser (VEL), as a non-ablative photothermal therapy for superficial dyspareunia in postmenopausal women (PMW) suffering from genitourinary syndrome of menopause (GSM). METHODS: Two groups of sexually active PMW reporting superficial dyspareunia were selected: one (15 patients, VEL) was treated using an erbium:yttrium-aluminum-garnet laser crystal (XS Fotona SMOOTH; Fotona, Ljubljana, Slovenia) with a wavelength of 2940 nm; in the other group (15 patients, VEL + Nd:YAG) this treatment was followed by Nd:YAG laser (Fotona SP Dynamis, PIANO mode) treatment. Treatment consisted of three laser applications at 30-day intervals. Symptoms were assessed before, after each laser application and after 1 and 3 months from the end of the treatment, using the subjective visual analog scale (VAS) for superficial dyspareunia. RESULTS: Both groups showed a rapid and significant improvement of superficial dyspareunia over time (p < 0.001) independently from age and years since menopause. The VEL + Nd:YAG group showed a greater improvement of superficial dyspareunia (p < 0.001); this difference was evident since the first treatment and remained stable over time. CONCLUSIONS: The addition of Nd:YAG to VEL may induce greater improvement in superficial dyspareunia in PMW with GSM. SN - 1473-0804 UR - https://www.unboundmedicine.com/medline/citation/35006008/Short-term_effects_of_an_erbium/neodymium_laser_combination_in_superficial_dyspareunia:_a_pilot_study. L2 - https://www.tandfonline.com/doi/full/10.1080/13697137.2021.2014809 DB - PRIME DP - Unbound Medicine ER -